PolyActiva’s Chief Scientific Officer, Michael Brubaker, Ph.D., will present a corporate overview of the company’s proprietary PREZIA™ drug delivery platform at Eyecelerator @ the American Academy of Ophthalmology (AAO) 2025 Annual Meeting on Thursday, October 16, 2025, in Orlando, Florida.